The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
Open accessAbstract
Paragangliomas are neuroendocrine tumors frequently associated with mutations in RET, NF1, VHL, and succinate dehydrogenase (SDHx) genes. Methylome analysis of a large paraganglioma cohort identified three stable clusters, associated with distinct clinical features and mutational status. SDHx-related tumors displayed a hypermethylator phenotype, associated with downregulation of key genes involved in neuroendocrine differentiation. Succinate accumulation in SDH-deficient mouse chromaffin cells led to DNA hypermethylation by inhibition of 2-OG-dependent histone and DNA demethylases and established a migratory phenotype reversed by decitabine treatment. Epigenetic silencing was particularly severe in SDHB-mutated tumors, potentially explaining their malignancy. Finally, inactivating FH mutations were identified in the only hypermethylated tumor without SDHx mutations. These findings emphasize the interplay between the Krebs cycle, epigenomic changes, and cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Like D-2HG, fumarate and succinate accumulation can inhibit some αKG-dependent dioxygenases, resulting in hypermethylation of DNA and histones in tumors exhibiting loss of FH or SDH (Hoekstra et al., 2015; Letouze et al., 2013; Xiao et al., 2012).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Letouze et al., 2013
In the citing paper
“In cancer cells, mutations in succinate dehydrogenase subunit B (SDHB) cause susceptibility to familial pheochromocytoma99 and familial paraganglioma100 as well as gastrointestinal stromal tumors101.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [100]
In the citing paper
“As succinate accumulates via the inhibition of the 2-OGDD enzyme, epigenetic modification acts in the process of cell transformation into a hypermethylated phenotype100.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [100]
In the citing paper
“Although additional studies are needed, ample experimental data support the recognition of R-2-HG, succinate, and fumarate as oncometabolites.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [100]
In the citing paper
“Several studies have shown that SDH-deficient cells exhibit increased tumorigenesis and that this increase is reversed by the addition of α-KG, supporting the idea that succinate accumulation contributes to tumorigenesis through epigenetic modification100.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [100]
In the citing paper
“Tumors that exhibit SDH- and FH loss share a number of phenotypic features that are consistent with dioxygenase inhibition, among which is a characteristic global increase in DNA methylation (Killian et al., 2013; Letouze et al., 2013; Xiao et al., 2012), as well as elevated levels of HIF1α (Selak et al., 2005).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Letouze et al., 2013
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
Krueger, F., & Andrews, S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr167 · Cited by 5,324
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,562
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,430
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267 · cited 1×
“As both H3K9 and H3K27 methylation are closely linked with DNA methylation (Cedar and Bergman, 2009), these effects on histone methylation may contribute to the establishment of the hypermethylator phenotype.”
BackgroundMonti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116
Cited by
Sorted by citations
Items 701–800 of 813
Genetics of Phaeochromocytomas, Paragangliomas, and Neuroblastoma
Maher, E. R., & Casey, R. T. (2022) · doi:10.1093/med/9780198870197.003.0097
Familial Syndromes and Genetic Causes of Paraganglioma and Phaeochromocytoma
Maher, E. R., & Casey, R. T. (2022) · doi:10.1093/med/9780198870197.003.0119
Energy Metabolism and Epigenetics
Bultman, S. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_87
Rôle de la succinate déshydrogénase dans le cancer
Moog, S., & Favier, J. (2022) · médecine/sciences · doi:10.1051/medsci/2022024 · Cited by 3
Self-citationTreviño, L. S., & Walker, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95610-1
Choate, K. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726744181.793558674
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37675-4.50202-7
Metabolic mapping of high-fit and low-fit individuals for human physiological health
Janssen, J. J. E. (2022) · doi:10.18174/573397
Pavlova, N. N., Rao, A. D., DeBerardinis, R. J., & Thompson, C. B. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm015.pub2
Hereditary Endocrine Tumor Registries
Moore, E. C., Ioannou, L., Ruseckaite, R., Serpell, J. W., & Ahern, S. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac194
“Of these, basic science was most commonly represented (80 papers [15-94]) followed by clinical outcome (30 papers [95-124]), quality and improvement (7 papers [125-131]), treatment (6 papers [132-137]), epidemiology (4 papers [98, 138-140]), patient-reported outcome (PRO) measure (1 paper [141]), and other (3 papers […”
BackgroundGoncalves, J., Moog, S., Morin, A., Gentric, G., Müller, S., Morrell, A. P., Kľučková, K., Stewart, T. J., Andoniadou, C. L., Lussey‐Lepoutre, C., et al. (2023) · doi:10.1158/0008-5472.c.6513153.v1
Self-citationKhatami, F., Reis, L. O., Ebrahimi, M., Nasiri, S., Tavangar, S. M., Pishkuhi, M. A., Shafiei, G., Heshmat, R., & Aghamir, S. M. K. (2023) · Preprints.org · doi:10.20944/preprints202304.0404.v1
Cecchini, M., Zhang, J. Y., Wei, W., Sklar, J., Lacy, J., Zhong, M., Kong, Y., Zhao, H., DiPalermo, J., Devine, L., et al. (2023) · doi:10.1158/2767-9764.23593088
Cecchini, M., Zhang, J. Y., Wei, W., Sklar, J., Lacy, J., Zhong, M., Kong, Y., Zhao, H., DiPalermo, J., Devine, L., et al. (2023) · doi:10.1158/2767-9764.23593088.v1
Miettinen, M. (2016) · Cambridge University Press eBooks · doi:10.1017/9781107707504.027
Molecular Pathology of Kidney Tumors
Al‐Obaidy, K. I., Alruwaii, Z. I., Mohanty, S. K., Liang Cheng, C., & Williamson, S. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-35118-1_13
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715128
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715101
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715137
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715158
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715152
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715104
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715113
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715125
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715173
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715161
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715107
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715116
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715170
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715176
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715119
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715122
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715110
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715140
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715143
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715134
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715164
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715167
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K. J., Srivastava, S., Chen, S., Wu, Z., Lee, H., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715146
Investigating the role of mitochondrial energy rewiring throughout prostate cancer progression
Bidgood, C. L. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.248849
Preclinic and Translational Research in Adrenal Malignancies
Rapizzi, E., Abate, A., Tamburello, M., Luconi, M., & Sigala, S. (2024) · Updates in surgery/Updates in surgery series · doi:10.1007/978-3-031-62301-1_20
Pheochromocytoma and paraganglioma: Management, genetics, and follow-up
Gimenez‐Roqueplo, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00111-4
Self-citationFilipowicz, A. R., Chen, Q., & Allard, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00139-x
Paraganglia and Paragangliomas
(2024) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477473-09
Multiple Endocrine Neoplasia and Familial Isolated Pituitary Adenoma in the Paediatric Population
Halász, Z., & Korbonits, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_36
Paediatric Paraganglioma with Variant of Unknown Significance on Genetic Testing
Ong, J. L., Pinto, D., Rajeev, R., & Parameswaran, R. (2025) · Case Reports in Oncology · doi:10.1159/000543615 · Cited by 1
“Loss of FH activity increases the fumarate level which is a competitive inhibitor of 2-OG-dependent dioxygenases and increases hypermethylation, and the tumours are generally associated with a higher metastatic potential [28].”
The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas
Jenčová, P., Vosecká, T., Štolová, L., Rychlá, M., Voříšková, D., Zelinka, T., Musil, Z., Guha, A., Duskova, J., Brož, P., et al. (2025) · Endocrine Related Cancer · doi:10.1530/erc-24-0330
A transcriptional biosensor reveals mechanisms of α-ketoglutarate signaling to chromatin
Sternisha, A. C., Li, H., Gajendra, K., Xiao, Y., Zhao, X., Traylor, J. I., Guo, L., Jun, J. H., Fleishman, M., Shipman, T., et al. (2026) · Science · doi:10.1126/science.adx8675
In vivo and in vitro analysis of functional effects of the SDHD H50R variant
Priya, S., Chakravarthy, K., Ziegler, E., Vesco, X., LaPerle, K., Zhang, X., & Kirschner, L. S. (2025) · Endocrine Related Cancer · doi:10.1530/erc-24-0337
The Function of Succinate Dehydrogenase in Maintaining Normal Health
Lari, M. Q., Kumar, D., Kumar, D., & Kumar, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-6831-1_2
Жуликов, Я. А., Kovalenko, E. I., Galanova, K. N., Tyatyushkina, A. N., Евдокимова, Е. В., Маркович, А. А., Bokhian, V., Gabrava, M. M., Martynova, O. Y., Delektorskaya, V. V., et al. (2025) · Medical alphabet · doi:10.33667/2078-5631-2025-11-49-54
Wang, X., Calucho, M., Estrada-Zuniga, C. M., Noureen, M., Gonzalez‐Cantu, H., Mossuto, S., Levi, J. N., Landry, B. N., Guo, Q., Rutherford, K. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.22.671868
Khazal, F. J. A., Emch, M. J., Correia, C., Favier, J., Hawse, J. R., & Maher, L. J., III (2026) · iScience · doi:10.1016/j.isci.2026.115885 · Cited by 2
“…is synthetically lethal with Sdhb loss in an adrenal medulla-derived immortalized murine cell line, but not in corresponding SDH-expressing cells, 13–15 we performed a genome-wide CRISPR-Cas9 knockout screen us-ing a mouse CRISPR knockout pooled library (Brie), 16 which carries 78,637 single…”
Self-citationChatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656936
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656891
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656924
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656888
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656933
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24883479
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656909
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656900
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656915
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656918
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K., Srivastava, S., Chen, S., Wu, Z., Lee, H.-O., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715149
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656903
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656894
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656921
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656939
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656930
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656912
Padmanabhan, N., Kyon, H. K., Boot, A., Lim, K., Srivastava, S., Chen, S., Wu, Z., Lee, H.-O., Mukundan, V. T., Chan, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715131
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656927
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656885
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J. G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656906
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J. G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656897
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J. G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24883827
Goncalves, P. D., & Sadow, P. M. (2026) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000528 · Cited by 1
Aklima, J., Jahan, I., Jahan, K., Barua, U., Touse, S. A., Ahmed, S., Parial, R., Baidya, S., & Noman, A. S. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041722
Endocrine hypertension in 2025: how AI and multiomics are revolutionizing detection
Fuentes‐Mendoza, J. M., Concepción‐Zavaleta, M. J., Mendoza-Godoy, J. J., Aldave, J. E. Q., Morón-Siguas, J. C., & Paz‐Ibarra, J. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2634025
“These neoplasms exhibit a distinct hypermethylator phenotype driven by succinate accumulation, which inhibits α-ketoglutarate – dependent dioxygenases, including DNA demethylation machinery such as TET enzymes and histone demethylases [77,78].”
Zhang, J., Rebel, H. G., Duesman, D., Dommering, C. J., Schepers, A., Devilee, P., & Bayley, J. (2026) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2797-3576
Classe, M. (2017) · theses.fr (ABES) · doi:10.70675/e9d57129zf812z42c4zb161zf119c8d906c3
“Ces phénotypes CIMP ont été rapportés dans des cancers du côlon (64), dans des cholangiocarcinomes (87), des paragangliomes (88) ou des gliomes (89).”
BackgroundTissot, F. S. (2017) · theses.fr (ABES) · doi:10.70675/15252dfez0dfez4a42z83f4z21be7c773c9d
Analyse de signatures transcriptomiques et épigénétiques des carcinomes hépatocellulaires
Meunier, L. (2020) · theses.fr (ABES) · doi:10.70675/d5e7c2e4zaff4z46eaza0fcza52f9c3d46f1
Étude de l’influence de la glutaminolyse des macrophages dans les maladies cardio-métaboliques
Merlin, J. (2020) · theses.fr (ABES) · doi:10.70675/68e10f28zf840z48bfz9bacz5511a3a2b208
Yoganathan, T. (2022) · theses.fr (ABES) · doi:10.70675/86147de9za574z463fzbad0z57552b0ff2a5
Streit, L. (2021) · theses.fr (ABES) · doi:10.70675/3269cd86zf5cez4e27z8df0zbfdff2079072
Impact des mutations SDH sur la réponse antitumorale et identification de nouveaux biomarqueurs
Lamy, C. (2021) · theses.fr (ABES) · doi:10.70675/036f6787z50daz43e6zbeafzbcebfb700048
Advances in laboratory diagnostic studies of pheochromocytoma and paraganglioma
Li, C., Li, L., Mu, D., Ma, Y., Gao, Y., Li, Y., & Cheng, X. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121100
Molecular overview of major salivary gland carcinomas in chilean patients: 2 case reports
Veas-Torres, J., Miranda, D. I., Chávez, F. S., Sáez, M., Avendaño, M. E., Abello, C. S. M., Villanueva, M. G., Barriga, F. S., Brito, M. N., la Torre, P. R. D., et al. (2026) · BMC Oral Health · doi:10.1186/s12903-026-09517-7
Genética de la neoplasia endocrina múltiple
Batanero, C. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-538-7.00014-9
Epigenetic regulation of non-apoptotic regulated cell death
El‐Sehrawy, A. A. M. A., Oriquat, G., Razyikova, L., Ne'matova, H., Ergashev, N., Ali, N. M., Bainsal, N., & Singh, R. (2026) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2026.151552
Genotype–location interaction defines the SSTR-PET phenotype in paragangliomas and pheochromocytomas
Impériale, A., Montanini, F., Baltzinger, P., Canu, L., Fasciglione, E., Rapizzi, E., Hubelé, F., Abenavoli, E., Nerattini, M., Zanatta, L., et al. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-08117-5
“These mechanisms may also be influenced by the molecular background of SDHx -related tumours, in which epigenetic alterations linked to SDH deficiency affect gene expression, cellular differentiation, and receptor regulation [27 , 28].”
Metabolic–epigenetic crosstalk in innate immune cell plasticity within the tumor microenvironment
Noh, J., Lee, J., You, C., & Kang, K. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01802-3 · Cited by 1
“These oncometabolites act as competitive inhibitors of α -KG-dependent dioxygenases, including TET DNA demethylases and Jumonji histone demethylases, leading to widespread DNA hypermethylation and transcriptional reprogramming 66,67 .”
Jiménez, C., Waguespack, S. G., Kaplan, J., Habra, M. A., & Varghese, J. M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag324
Xu, L. P., Xu, Z., Su, C., Zhao, Y., Qiang, L., Jing, X., & Sun, Y. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.71082
Metadata
- Authors
- Letouzé, E., Martinelli, C., Loriot, C., Burnichon, N., Abermil, N., Ottolenghi, C., Janin, M., Menara, M., Nguyen, A. T., Benit, P., Buffet, A., Marcaillou, C., Bertherat, J., Amar, L., Rustin, P., De Reyniès, A., Gimenez-Roqueplo, A.-P., & Favier, J.
- Affiliations
- Inserm (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Necker-Enfants Malades (FR)
- IntegraGen (France) (FR)
- Corresponding author
- Favier, Judith
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 23
- Issue
- 6
- Pages
- 739-752
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2061662711
- Semantic Scholar
- 12ff63634482848e635a81bd0e943c6b9634ac9a
- Cited by
- 776
- References
- 60
- Citations by year
- 2026: 41 · 2025: 34 · 2024: 61 · 2023: 55 · 2022: 53 · 2021: 65 · 2020: 53 · 2019: 70 · 2018: 59 · 2017: 79 · 2016: 58 · 2015: 73 · 2014: 50 · 2013: 22
- FWCI
- 66.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agence Nationale de la Recherche
- Core Research for Evolutional Science and Technology
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Keywords
- paraganglioma, succinate dehydrogenase, SDHB mutation, DNA hypermethylation, succinate accumulation, epigenetic silencing, neuroendocrine differentiation, FH mutations, decitabine, chromaffin cells, TCA cycle, tumor malignancy
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Cell Movement, Child, Female, Glioblastoma, Histones, Humans, Male, Middle Aged, Paraganglioma, Phenotype, Pheochromocytoma, Succinate Dehydrogenase, Colorectal Neoplasms, DNA Methylation, Chromaffin Cells, Gene Silencing, Epigenesis, Genetic, Mice, Gene Knockout Techniques, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
